148 related articles for article (PubMed ID: 28100578)
1. Ocular surface squamous neoplasia treated with topical interferon α 2b.
Pujari A
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28100578
[No Abstract] [Full Text] [Related]
2. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
Kusumesh R; Ambastha A; Sinha B; Kumar R
Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
[TBL] [Abstract][Full Text] [Related]
3. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N
Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688
[TBL] [Abstract][Full Text] [Related]
4. [Interferon alpha 2b eyedrops as treatment of conjunctival intraepithelial neoplasia].
Huerva V; Mangues I; Schoenenberger JA
Farm Hosp; 2009; 33(6):335-6. PubMed ID: 20038393
[No Abstract] [Full Text] [Related]
5. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
[TBL] [Abstract][Full Text] [Related]
6. Interferon alpha-2b in giant ocular surface squamous neoplasia.
Hernandez-Bogantes E; Serna-Ojeda JC; Lichtinger A; Graue-Hernández EO
Indian J Ophthalmol; 2016 May; 64(5):393-4. PubMed ID: 27380981
[No Abstract] [Full Text] [Related]
7. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
[TBL] [Abstract][Full Text] [Related]
8. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
Sturges A; Butt AL; Lai JE; Chodosh J
Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
[TBL] [Abstract][Full Text] [Related]
9. Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.
Huerva V; Mangues I
J Fr Ophtalmol; 2008 Mar; 31(3):317-25. PubMed ID: 18404128
[TBL] [Abstract][Full Text] [Related]
10. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
[TBL] [Abstract][Full Text] [Related]
11. Interferon alpha-2a as alternative treatment for conjunctival squamous cell carcinoma.
Cruzado-Sánchez D; Salas-Diaz M; Tellez WA; Alvarez-Matos SE; Serpa-Frías S
Arch Soc Esp Oftalmol; 2017 Nov; 92(11):539-542. PubMed ID: 28522115
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Boehm MD; Huang AJ
Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
[TBL] [Abstract][Full Text] [Related]
13. Application of interferon alpha 2b in conjunctival intraepithelial neoplasia: predictors and prognostic factors.
Muñoz de Escalona Rojas JE; García Serrano JL; Cantero Hinojosa J; Padilla Torres JF; Bellido Muñoz RM
J Ocul Pharmacol Ther; 2014 Aug; 30(6):489-94. PubMed ID: 24749813
[TBL] [Abstract][Full Text] [Related]
14. Amniotic Membrane Grafting for Ocular Surface Inflammation Following Topical Interferon Alpha 2b Therapy.
Shah SG; Mishra DK; Shah GY
J Interferon Cytokine Res; 2022 Mar; 42(3):137-139. PubMed ID: 35298286
[TBL] [Abstract][Full Text] [Related]
15. Immunoreduction of ocular surface tumours with intralesional interferon alpha-2a.
Kim SE; Salvi SM
Eye (Lond); 2018 Feb; 32(2):460-462. PubMed ID: 28937145
[TBL] [Abstract][Full Text] [Related]
16. [Topical interferon alpha 2 beta therapy in the management of conjunctival intraepithelial neoplasia].
Albornoz López R; Fernández García MI; Pérez Rodrigo I
Farm Hosp; 2007; 31(6):382-4. PubMed ID: 18348671
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b.
Pérez-García P; Burgos-Blasco B; Gómez-Calleja V; Vidal-Villegas B; Méndez-Fernández R; Gegúndez-Fernández JA; Díaz-Valle D
J Oncol Pharm Pract; 2023 Jun; 29(4):975-979. PubMed ID: 36131486
[TBL] [Abstract][Full Text] [Related]
18. Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b.
Esquenazi S; Fry CL; Holley E
Br J Ophthalmol; 2005 Sep; 89(9):1221. PubMed ID: 16113387
[No Abstract] [Full Text] [Related]
19. [Topical interferon alfa-2b or surgical excision for primary treatment of conjunctiva-cornea intraepithelial neoplasia].
Huerva V
Arch Soc Esp Oftalmol; 2009 Jan; 84(1):5-6. PubMed ID: 19173133
[No Abstract] [Full Text] [Related]
20. Topical interferon alpha-2B topic as the first therapeutic option in a clinical case of conjunctival intraepithelial neoplasia.
Pagán Carrasco S; Arranz Maestro D
Arch Soc Esp Oftalmol; 2017 Sep; 92(9):442-446. PubMed ID: 28292536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
